ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1277

A Pilot Study Of Young Adults With Juvenile Dermatomyositis With Decreased Nailfold Capillary End Row Loops:  Brachial Artery Reactivity and Oxidized Lipids

Lauren M. Pachman1,2, Maureen A. McMahon3, Tamar Polonsky4, Gabrielle A. Morgan1, Maria Amoruso5 and Chiang-Ching Huang6, 1Cure JM Myositis Center, Ann & Robert H. Lurie Children's Hospital of Chicago Research Center, Chicago, IL, 2Division of Pediatric Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Division of Rheumatology, UCLA David Geffen School of Medicine, Los Angeles, CA, 4Cardiology, University of Chicago Medicine, Chicago, IL, 5Stanley Manne Children’s Research Institute, affiliated with Ann & Robert H. Lurie Children’s Hospital of Chicago, Cure JM Myositis Center, Chicago, IL, 6Zilber School of Public Health, University of Wisconsin at Milwaukee, Milwaukee, WI

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Atherosclerosis, dermatomyositis, Heart disease, lipids and pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects II: Pediatric Systemic Lupus Erythematosus, Pediatric Vasculitis and Pediatric Myositis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Our center previously reported increased carotid intima media thickness, and lower high-density lipoprotein (HDL) levels in young or middle-age adults with a history of JDM, who were not taking medication for JDM symptoms compared to normal controls.  Whether even younger adults with JDM have evidence of subclinical cardiovascular disease (CVD) is not known.

Objective: To determine whether an inception cohort of young adults with JDM have lower brachial artery reactivity (BAR) or HDL antioxidant function compared to normal controls.

Methods: After obtaining informed consent, we enrolled an inception cohort of 20 white adults, 14 F, mean age at study 21.8± 4.2 years, and mean age at JDM onset 7.6 ± 3.7 years, mean duration of untreated disease (DUD) at diagnosis 5.4 ± 4.8 months, and mean total duration of disease 14.2 ±3.9 years. JDM adults had a mean Total disease activity score (DAS) 1.9 ± 2.5, but were not taking medications for JDM symptoms.  They were matched by age, race, sex and BMI with 20 healthy volunteers (mean age 23.8 ± 4.2 years).  Both groups were tested for: BAR, nailfold capillary end row loop number (ERL), height and weight.  To determine the antioxidant function of HDL, we measured change in fluorescence intensity caused by oxidation of dichlorfluorescein-diacetate by oxidized low density lipoprotein ±HDL. Fluorescence in the absence of HDL was normalized to 1.0.  Values greater than 1.0 after the addition of HDL indicated pro-inflammatory HDL (mean HDL function in healthy controls ranges from 0.44 to 0.66).

BAR reflects endothelial function. Normal endothelial cells release nitric oxide in response to sheer stress, causing vasodilation. For BAR measurement individuals presented fasting, and lay supine in a temperature-controlled room for 10 minutes before imaging.  Brachial artery diameter was measured with an 8L5 linear array transducer, 1 cm distal to the antecubital fossa. To create sheer stress, a BP cuff was inflated 50 mm Hg above the baseline BP for 4.5 min. Brachial artery diameter was then re-measured 60 seconds after cuff deflation.  BAR was defined as [(post-deflation – baseline diameter)/baseline diameter] x100%.

Results: The ERL numbers were significantly different in the JDM group, 6.35 ± 1.29 vs the controls, 7.4±0.58, p=0.003. The TNF-α -308A allele was increased in the JDM group 40% vs 15% in controls (p=0.15 ).  Of note, the group with JDM were shorter in stature than their controls, for both JDM women, 159.7 ±8.8 cm vs 165.6 ±5.4 cm, p=0.048, and for JDM men, 172.7±3.6cm compared to controls, 181.5 ±4.6cm, p=0.0046.  BAR in adults with JDM was 3.35±3.06%, and 5.22±3.07%- in normal controls (p=0.068). After adjusting for height and sex, BAR in adults with JDM was significantly decreased by 2.78 unit when compared with controls (p=0.018). There was no significant association of BAR values with the following:  ERL, DUD, or DAS.  The oxidized lipids did not differ between the JDM and controls.

Conclusion: The decrease in height in JDM may be a consequence of previous corticosteroid administration. The data show a marginal association of BAR in JDM, p=0.068 and a significant association with decreased BAR, p=0.018 after adjustment for height. Larger studies in young adults with JDM are needed to validate our finding.


Disclosure:

L. M. Pachman,
None;

M. A. McMahon,

GlaxoSmithKline,

8;

T. Polonsky,
None;

G. A. Morgan,
None;

M. Amoruso,
None;

C. C. Huang,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-pilot-study-of-young-adults-with-juvenile-dermatomyositis-with-decreased-nailfold-capillary-end-row-loops-brachial-artery-reactivity-and-oxidized-lipids/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology